The associated cancer phenotype in heterozygous carriers of germline pathogenic variants in CDH1 reflects a loss of function of E-cadherin, with increased risks of diffuse subtypes of gastric cancer, and/or lobular subtypes of breast cancer. This evidence concerns the gene CDH1 and breast carcinoma.